Refractory portal hypertension complications successfully managed by parallel transjugular intrahepatic portosystemic shunt (TIPS): a case report.

Weeratunga, Senali; Nambiar, Mithun; Handley, Charles; Florescu, Cosmin; Lyon, Stuart M; Le, Suong; De Boo, Diederick W

Weeratunga, Senali; Nambiar, Mithun; Handley, Charles; Florescu, Cosmin; Lyon, Stuart M; Le, Suong; De Boo, Diederick W.

Afiliação

Weeratunga S; Monash Imaging, Monash Medical Centre, Clayton, Victoria, Australia.
Nambiar M; Monash Imaging, Monash Medical Centre, Clayton, Victoria, Australia.
Handley C; Faculty of Medicine, Nursing and Health Science, Monash University, Clayton, Victoria, Australia.
Florescu C; Monash Imaging, Monash Medical Centre, Clayton, Victoria, Australia.
Lyon SM; School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.
Le S; Monash Imaging, Monash Medical Centre, Clayton, Victoria, Australia.
De Boo DW; Monash Imaging, Monash Medical Centre, Clayton, Victoria, Australia.

CVIR Endovasc ; 5(1): 20, 2022 Apr 18.

Article em En | MEDLINE | ID: mdl-35435518

ABSTRACT

ABSTRACT

BACKGROUND:

Transjugular intrahepatic portosystemic shunt (TIPS) is an established intervention to treat complicated portal hypertension refractory to medical or endoscopic management. TIPS dysfunction results in the recurrence of portal hypertension symptoms. In cases of TIPS dysfunction or persistent portal hypertension despite a patent primary TIPS, the creation of parallel TIPS may be the only intervention to effectively reduce portal pressure. Since the introduction of dedicated TIPS stents (Viatorr®) the incidence of TIPS dysfunction has reduced profoundly. Nevertheless, the creation of a parallel TIPS can still be necessary in the current dedicated TIPS stent era. CASE PRESENTATION We report one such patient who experienced ongoing portal hypertension induced upper gastro-intestinal haemorrhage despite multiple TIPS revisions and a patent primary TIPS.